Geode Capital Management
VTAK icon

Geode Capital Management’s Catheter Precision VTAK Stock Holding History

Geode Capital Management’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Sell
11,977
-35,682
-75% -$33.9K ﹤0.01% 4420
2026
Q1 		$48.1K Buy
+47,659
New +$80.8K ﹤0.01% 4326
2025
Q3 		– Sell
-2,853
Closed -$13.1K – 4570
2025
Q2 		$13.1K Hold
2,853
– – ﹤0.01% 4409
2025
Q1 		$18.6K Buy
+2,853
New +$21.6K ﹤0.01% 4361
2024
Q2 		– Sell
-155
Closed -$14.3K – 4626
2024
Q1 		$14.3K Hold
155
– – ﹤0.01% 4519
2023
Q4 		$11.9K Hold
155
– – ﹤0.01% 4574
2023
Q3 		$13.1K Buy
155
+86
+125% +$9.99K ﹤0.01% 4691
2023
Q2 		$12.1K Sell
69
-1
-1% -$231 ﹤0.01% 4703
2023
Q1 		$20.4K Sell
70
-1
-1% -$543 ﹤0.01% 4700
2022
Q4 		$79K Buy
71
+63
+788% +$52.2K ﹤0.01% 4475
2022
Q3 		$9K Hold
8
– – ﹤0.01% 4995
2022
Q2 		$23K Buy
8
+4
+100% +$12.4K ﹤0.01% 4904
2022
Q1 		$16K Hold
4
– – ﹤0.01% 4941
2021
Q4 		$65K Hold
4
– – ﹤0.01% 4815
2021
Q3 		$131K Buy
4
+2
+100% +$62.9K ﹤0.01% 4598
2021
Q2 		$64K Hold
2
– – ﹤0.01% 4628
2021
Q1 		$69K Buy
+2
New +$131K ﹤0.01% 4361

Other funds holding VTAK

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Geode Capital Management's VTAK Position: Q2 2026 in Review

Geode Capital Management reduced its Catheter Precision (VTAK) stake by 75% in Q2 2026, selling an estimated $33.9K and leaving 11,977 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4420.

Geode Capital Management first reported a position in VTAK in Q1 2021 and has held it in 17 quarters since. The position peaked at $131K in Q3 2021. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.

  • Geode Capital Management held 11,977 shares of Catheter Precision worth $10.2K as of Q2 2026.
  • Geode Capital Management sold 35,682 Catheter Precision shares in Q2 2026, an estimated $33.9K.
  • Catheter Precision made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4420 holding.
  • Geode Capital Management first reported a position in Catheter Precision in Q1 2021 and has held it in 17 quarters since.
  • Geode Capital Management's Catheter Precision position peaked at $131K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.